J. H. Loh

Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma

B. Au, J. Connolly, P. Chow, 2020, Journal for ImmunoTherapy of Cancer.

Expression of CD38 on Macrophages Predicts Improved Prognosis in Hepatocellular Carcinoma

S. Choo, T. Lim, C. Chan, 2019, Front. Immunol..

Immunological Hallmarks for Clinical Response to BCG in Bladder Cancer

C. J. Lim, T. Lim, S. Albani, 2021, Frontiers in Immunology.

CD38 is a good predictor of anti-PD-1 immunotherapy responsiveness in hepatocellular carcinoma

P. Chow, E. Newell, S. Choo, 2019, bioRxiv.

An integrated automated multispectral imaging technique that simultaneously detects and quantitates viral RNA and immune cell protein markers in fixed sections from Epstein-Barr virus-related tumours.

E. Newell, T. Lim, A. Takano, 2018, Annals of diagnostic pathology.